September 2022 - Pharmaceutical Market Europe

September 2022 - Pharmaceutical Market Europe
Published on 7 September 2022

Description:

The importance of support programmes to improve patient health; the fight against antimicrobial resistance; future-proofing pharma supply chains

Preview:

34 articles from this collection:
PME September 2022
PME September 2022
2 - FLYPHARMA
2 - FLYPHARMA
3 - Comment
3 - Comment
4 - PMLIVE/PME
4 - PMLIVE/PME
5 - Contents
5 - Contents
6-7 - News
6-7 - News
6-7 - PME - Pharma Market Europe Pharmaceutical News
8-9 - News
8-9 - News
10-11 - Coronavirus news
10-11 - Coronavirus news
12 - DARWIN'S MEDICINE - Longevity Lessons
12 - DARWIN'S MEDICINE - Longevity Lessons
12 - Pharma Market Europe Darwin’s medicine
13 - POLICY AND PUBLIC HEALTH - The holy grail of healthcare pricing
13 - POLICY AND PUBLIC HEALTH - The holy grail of healthcare pricing
The technology responses to this pandemic have fallen far short of expectations
14 - MIKE DIXON - In an emergency, what  is your first response?
14 - MIKE DIXON - In an emergency, what is your first response?
15 - TL BEDROCK - Creating strong employee engagement and retaining talent in the new normal
15 - TL BEDROCK - Creating strong employee engagement and retaining talent in the new normal
16 - PHARMA STARTEGISTS’ BLOG - Agile strategy or strategy for ‘Agile’?
16 - PHARMA STARTEGISTS’ BLOG - Agile strategy or strategy for ‘Agile’?
17 - TL EVOKE KYNE: Thriving, not surviving – a hybrid mentality
17 - TL EVOKE KYNE: Thriving, not surviving – a hybrid mentality
18-19 - ANTIMICROBIAL RESISTANCE: The fight against antimicrobial resistance
18-19 - ANTIMICROBIAL RESISTANCE: The fight against antimicrobial resistance
20 - TL - ORIGINS – The value of patient reported outcomes
20 - TL - ORIGINS – The value of patient reported outcomes
21 - TL - DAIICHI-SANKYO - Collaboration over complacency in reshaping the future of cardiovascular care
21 - TL - DAIICHI-SANKYO - Collaboration over complacency in reshaping the future of cardiovascular care
22-23 - TL HANOVER - How AI is finally helping rare diseases gain more than just attention
22-23 - TL HANOVER - How AI is finally helping rare diseases gain more than just attention
24-25 - PANDEMIC PREPAREDNESS: Future-proofing pharma supply chains by improving inefficiencies in global health architecture
24-25 - PANDEMIC PREPAREDNESS: Future-proofing pharma supply chains by improving inefficiencies in global health architecture
26-27 - WOMEN'S HEALTH: Envisioning a healthier every day, for every woman
26-27 - WOMEN'S HEALTH: Envisioning a healthier every day, for every woman
28 - FLYPHARMA
28 - FLYPHARMA
29 - TL ANTHEM PR - The benefits of patient support programmes in specific disease areas
29 - TL ANTHEM PR - The benefits of patient support programmes in specific disease areas
30-32 - PATIENT SUPPORT PROGRAMMES - Building a brighter future with patient support programmes
30-32 - PATIENT SUPPORT PROGRAMMES - Building a brighter future with patient support programmes
33 - TL PURPLE AGENCY - ‘Patient support programmes: providing meaningful care when you dare to treat rare
33 - TL PURPLE AGENCY - ‘Patient support programmes: providing meaningful care when you dare to treat rare
34 - TL SPROUT HEALTH SOLUTIONS - Creating patient support programmes that help patients thrive
34 - TL SPROUT HEALTH SOLUTIONS - Creating patient support programmes that help patients thrive
35 - TL VISFO HEALTH - Looking to the future of patient empowerment
35 - TL VISFO HEALTH - Looking to the future of patient empowerment
36-37 - CUSTOMER ENGAGEMENT - Customers, content and change
36-37 - CUSTOMER ENGAGEMENT - Customers, content and change
38-39 - PHARMA'S UKRAINE CRISIS RESPONSE
38-39 - PHARMA'S UKRAINE CRISIS RESPONSE
40-41 -  MEDTECH AND HEALTHCARE - The future of medtech is in the past
40-41 - MEDTECH AND HEALTHCARE - The future of medtech is in the past
42-44 - Appointments
42-44 - Appointments
45 -  HEALTHCARE COMMS
45 - HEALTHCARE COMMS
46 - PMLIVE
46 - PMLIVE
47 - Recruitment
47 - Recruitment
43 - Pharma Market Europe (PME) Recruitment
48 - MOY
48 - MOY